INFOSYS ALLEGES FORMER PRESIDENT KUMAR SLOWED PROJECTS TO BENEFIT COGNIZANT

Infosys filed a counterclaim against Cognizant in a US court, alleging that its rival Cognizant and its CEO, Ravi Kumar, engaged in anticompetitive practices to stifle competition and maintain dominance in the healthcare payer software market. Infosys demanded a jury trial and sought triple compensation for damages incurred, along with appropriate legal fees and expenses.

This development came six months after Cognizant filed a lawsuit against Infosys, alleging that the latter stole proprietary information related to its health tech subsidiary, TriZetto. Cognizant acquired the healthcare tech firm TriZetto for $2.7 billion in 2014.

Learn More